|
|
|
|
|
|
|
|
Note: 'never-events' is a term used in patient safety (eg. language - near misses, etc)
Conclusions.
"Women with CCC-O have a 2.5-times greater risk of disease related VTE than women with other histologies of epithelial ovarian cancer despite adherence to prophylactic guidelines. Given the high rate of VTE postoperatively as well as with disease recurrence, one should consider indefinite therapeutic anticoagulation in women with CCC-O. The case of CCC-O is one example of the impracticality of payment denial for ‘never-events,’ as VTE arises despite best efforts at prevention."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.